Company
Headquarters: Korneuburg, Austria
Employees: 289,282
CEO: Mr. Ola Kallenius
€59.70 Billion
EUR as of Jan. 1, 2026
US$70.11 Billion
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $158.96 B |
| Vertex Pharmaceuticals Incorporated | $115.92 B |
| CSL Limited | $95.75 B |
| Regeneron Pharmaceuticals, Inc. | $82.28 B |
| Samsung Biologics Co.,Ltd. | $54.01 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Mercedes-Benz Group AG operates as an automotive company in Germany and internationally. The company develops, manufactures, and sells passenger cars comprising premium and luxury vehicles of the Mercedes-Benz brand, including the Mercedes-AMG, Mercedes-Maybach, and Mercedes-EQ brands, as well as small cars under the smart brand; ecosystem of Mercedes-Benz under the Mercedes me brand; and vans under the Mercedes-Benz and Freightliner brands, as well as related spare parts and accessories. It also provides financing and leasing packages for end-customers and dealers; automotive insurance brokerage and banking services; car subscription and car rental, and fleet management, as well as digital services for charging and payment; and mobility services. The company was formerly known as Daimler AG and changed its name to Mercedes-Benz Group AG in February 2022. Mercedes-Benz Group AG was founded in 1886 and is headquartered in Stuttgart, Germany.
| Last Financial Reports Date | June 30, 2025 |
| Revenue TTM | €136.97 B |
| EBITDA | €17.46 B |
| Gross Profit TTM | €22.67 B |
| Profit Margin | 4.56% |
| Operating Margin | 1.23% |
| Quarterly Revenue Growth | -6.90% |
Marinomed Biotech AG has the following listings and related stock indices.
Stock: FSX: MBG wb_incandescent